NCT06292962View on ClinicalTrials.gov

Evaluating the Impact of Vagus Nerve Stimulation on Diabetic Peripheral Neuropathic Pain

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 3, 2024

Conditions
Diabetes MellitusDiabetic NeuropathiesType2diabetesNeuropathic Pain
Interventions
DEVICE

non-invasive transcutaneous vagal nerve stimulation (tVNS)

The device is used stimulate the vagus nerve

DEVICE

Sham device

Sham device that does not stimulate the vagus nerve

Trial Locations (1)

Unknown

Shifa Hospital, Lahore

All Listed Sponsors
collaborator

Al Ain University

UNKNOWN

lead

Saima Abass Tahammal

OTHER

NCT06292962 - Evaluating the Impact of Vagus Nerve Stimulation on Diabetic Peripheral Neuropathic Pain | Biotech Hunter | Biotech Hunter